CAS 1383719-97-8

PF 04628935

CAS: 1383719-97-8

PF 04628935 is a ghrelin receptor antagonist. It has been shown to have serotonergic, neuroprotective and neurogenic effects. PF 04628935 has been shown to regulate the release of neurotransmitters in the brain, which may be due to its ability to inhibit the binding of serotonin to 5-HT1A receptors. It also has an effect on the central nervous system by activating serotonergic receptors in the brain and inhibiting their deactivation by serotonin. This drug also has neuroprotective activity, as it can neutralize reactive oxygen species and prevent lipid peroxidation. PF 04628935 blocks 5-HT2A receptors with selectivity, preventing activation of these receptors by serotonin and antagonizing hallucinogenic effects caused by drugs such as LSD or psilocybin. This drug also inhibits 5-HT7 receptors, which may contribute to its effects on mood regulation and appetite suppression.

Formel: C₂₄H₂₆ClN₇OS

Reinheit: Min. 95%

Molekulargewicht: 496.03 g/mol

Ref: 3D-IFC71997

PF-04628935

CAS: 1383719-97-8

PF-04628935: potent GHS-R1a antagonist/inverse agonist, IC50=4.6 nM, orally bioavailable, brain penetrant.

Formel: C₂₄H₂₆ClN₇OS

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 496.03

Ref: TM-T28366